The technosphere insulin inhalation powder (TI) is a non-invasive insulin inhalant that is used to help decrease blood glucose following meals in both type 1 and 2 diabetes patients….

  Study subjects who had the hepatitis B vaccination had an 81% reduction in diabetes risk….

African Americans with type 2 diabetes respond better to metformin’s glucose lowering effects….

When Steve and Andrew got back from the ADA’s 74th Scientific Sessions in San Francisco, we put together an awesome overview of some of the new research and studies on GLP-1. Now that we have had some time to review the entire program we are providing you with more of …

When Steve and Andrew got back from the scientific sessions in San Francisco we put together an awesome overview of some of the new research and studies on GLP-1. Now that we have had some time to review the entire list of GLP-1 related presentations we are proud to provide …

  You may have heard of DeFronzo’s "Ominous Octet" but have you heard of the "Disharmonious Quartet"? In this week’s Homerun Slides, we review the Pathogenesis of Type 2 Diabetes as well as the Role of Free Fatty Acids in Hyperglycemia where the Disharmonious Quartet comes into play….

Richard S. Beaser, MD This week’s excerpt covers the following topics: What drugs restore incretin function How to titrate GLP-1 agonists Learn the contraindications and precautions for the DPP-IV inhibitors The typical doses for the different DPP-IV’s….

Dr. Tamara Hannon gives us a brief introduction to herself and her work, and explains the focus of some of her research and that we need to be just as aggressive treating type 2 diabetes in children and adolescents as we currently are in treating type 1 diabetes.

Dr. Tamara Hannon reviews the current standards of care and recommended medications for treating type 2 diabetes in children and adolescents. She discusses the value of the TODAY study and how we need many more studies like this to improve care for this important and increasing group of type 2 …

Dr. Tamara Hannon talks about the increasing prevalence of type 2 in children and adolescents but reiterates that it is still less common to see type 2 than type 1 diabetes in this age group. She comments that in 2002, when she began her practice, that she saw just a …